- Ministry of Health — Ministerio de Salud (Minsal)
Sets national medical cannabis policy under Ley 21.020. Oversees ISP and SEREMI. Chile has a well-established medical cannabis framework since 2017.
- National cannabis policy under Ley 21.020
- Oversight of ISP pharmaceutical regulation
- Patient access guidelines
- ISP — Instituto de Salud Pública
Public Health Institute. Primary regulatory authority for medical cannabis. Issues import authorizations, manufacturing licenses, product registrations, and GMP certification. Manages cannabis-specific registry.
- Import authorization per shipment
- Manufacturing and GMP certification
- Product registration (Registro Sanitario)
- Cannabis-specific regulations under Ley 21.020
- SEREMI — Secretaría Regional Ministerial de Salud
Regional Ministerial Secretariats of Health. Implement ISP policy at regional level. Conduct pharmacy inspections and enforce controlled substance regulations at the local level.
- Regional enforcement of ISP regulations
- Pharmacy inspections
- Controlled substance monitoring
- Licensed Producers — Growing sector
Chile's domestic cannabis production sector is expanding. Several licensed producers operate under ISP oversight for both domestic supply and emerging export ambitions. Magistral preparation pathway supports compounding pharmacies.
- ISP manufacturing license
- GMP certification (ISP/Chilean GMP)
- GACP certification for cultivation sites
- Patients — Medical cannabis access
Patients access medical cannabis through medical prescription. Chile permits magistral preparation (compounding) as the primary access pathway, alongside registered pharmaceutical products.